for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up
Healthcare

BRIEF-Beigene And Medison Pharma Announce Exclusive Distribution Agreement And Acceptance Of New Drug Application For Btk Inhibitor Brukinsa™ In Israel

May 21 (Reuters) - Beigene Ltd:

* BEIGENE AND MEDISON PHARMA ANNOUNCE EXCLUSIVE DISTRIBUTION AGREEMENT AND ACCEPTANCE OF NEW DRUG APPLICATION FOR BTK INHIBITOR BRUKINSA™ (ZANUBRUTINIB) IN ISRAEL Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up